Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol,Thoracic Cancer

当前位置： X-MOL 学术 › Thorac. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive-stage small cell lung cancer (ES-SCLC): Study protocol
Thoracic Cancer ( IF 2.9 ) Pub Date : 2024-03-01 , DOI: 10.1111/1759-7714.15263
Lei Deng ₁ , Gulidanna Shayan ₁ , Wei Jiang ₂ , Nan Bi ₁ , Luhua Wang ₂

Affiliation

Consolidative thoracic radiotherapy (cTRT) has previously shown benefit to patients with extensive stage small cell lung cancer (ES-SCLC) who respond to chemotherapy. However, the optimum dose of cTRT is unknown. The purpose of this randomized trial is to compare the efficacy of 45 Gy in 15 fractions with 30 Gy in 10 fractions cTRT in ES-SCLC.

中文翻译：

45 Gy 与 30 Gy 胸部放射治疗广泛期小细胞肺癌 (ES-SCLC) 的 III 期、多中心、随机试验：研究方案

胸部巩固放疗 (cTRT) 此前已显示出对化疗有反应的广泛期小细胞肺癌 (ES-SCLC) 患者的益处。然而，cTRT 的最佳剂量尚不清楚。该随机试验的目的是比较 ES-SCLC 中 45 Gy（15 次）和 30 Gy（10 次）cTRT 的疗效。

更新日期：2024-03-01

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>